Picture of Akari Therapeutics logo

AKTX Akari Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Brief: Akari Therapeutics Announces Publication Of Phase Ii Data Of Investigational Nomacopan For The Treatment Of Bullous Pemphigoid (BP) In Jama Dermatology

May 10 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS ANNOUNCES PUBLICATION OF PHASE II DATA
OF
INVESTIGATIONAL NOMACOPAN FOR THE TREATMENT OF BULLOUS
PEMPHIGOID (BP) IN JAMA DERMATOLOGY

Source text for Eikon:  ID:nGNX7mL4gK 
Further company coverage:  AKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Akari Therapeutics

See all news